Skye Bioscience: Promising Nimacimab Data Supports Buy Rating
Skye Bioscience Inc.Skye Bioscience Inc.(US:SKYE) Seeking Alpha·2025-10-01 22:45

股票表现 - Skye Bioscience公司股票本月表现良好，实现两位数涨幅，且在过去的6个月内涨幅更为强劲，达到145% [1]